Modular program-based one-time assessment of the incident use of antipsychotics, including aripiprazole, asenapine, clozapine, iloperidone, lurasidone, olanzapine, paliperidone, quetiapine, risperidone, and ziprasidone, among patients without a pre-existing condition of schizophrenia spectrum disorder or bipolar I disorder and those with a pre-existing condition of schizophrenia spectrum disorder or bipolar I disorder. The query was run against the Mini-Sentinel Distributed Database (MSDD) for the time period of August 1, 2009 to September 30, 2011. Modular programs are adaptable standardized programs. Results were generated using Modular Program 3; click here for more information. Queries were distributed in October 2012. This report includes data from 16 Data Partners.
If you are using a web page screen reader and are unable to access this document, please contact the Mini-Sentinel Operations Center for assistance by clicking on the Submit Comments link above or sending an email requesting assistance to email@example.com.
The information contained on this website is provided as part of FDA's commitment to place knowledge acquired from the Mini-Sentinel pilot in the public domain as soon as possible. Please read the disclaimer.